Operating Margin (Quarterly)

Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues

Pfizer Inc. (PFE) had Operating Margin of 22.14% for the most recently reported fiscal quarter, ending 2026-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-09-30

Income Statement Financials
Revenue	$16.58B
Net Income	$3.24B
Cost of Goods Sold	$4.03B
Gross Profit	$12.55B
Operating Expenses	$12.91B
Operating Income	$3.67B
Non-Operating Income/Expense	$-288.00M
Pre-Tax Income	$3.38B
Normalized Pre-Tax Income	$3.38B
Income after Taxes	$3.25B
Income from Continuous Operations	$3.25B
Consolidated Net Income/Loss	$3.25B
Normalized Income after Taxes	$3.25B
EBIT	$3.67B
EBITDA	$5.25B
Weighted-Average Shares Outstanding (Basic)	5.70B
Weighted-Average Shares Outstanding (Diluted)	5.75B
Earnings per Share (EPS) (Basic)	$0.57
Earnings per Share (EPS) (Diluted)	$0.56
Balance Sheet Financials
Current Assets	$45.01B
Property, Plant, and Equipment	$19.05B
Long-Term Assets	$159.54B
Total Assets	$204.54B
Current Liabilities	$31.73B
Long-Term Debt	$60.00B
Long-Term Liabilities	$83.52B
Total Liabilities	$115.24B
Common Equity	$89.30B
Tangible Shareholders Equity	$-28.12B
Shareholders Equity	$89.30B
Common Shares Outstanding	5.70B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$8.82B
Cash Flow from Investing Activities	$865.00M
Cash Flow from Financial Activities	$-9.03B
Beginning Cash	$1.20B
End Cash	$1.88B
Increase/Decrease in Cash	$681.00M
Stock-Based Compensation	$883.00M
Common Stock Dividends Paid	$-7.35B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.42
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.70
Gross Margin	75.71%
Operating Margin	22.14%
EBIT Margin	22.14%
EBITDA Margin	--
Pre-Tax Profit Margin	20.41%
Profit Margin	19.55%
Free Cash Flow	$7.28B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	0.40
Receiveable Turnover	1.17
Days Sales in Receivables	77.02
Return on Equity	3.64%
Return on Tangible Equity	-11.56%
Return on Assets	1.59%
Return on Investments	2.18%
Book Value Per Share	$15.67
Free Cash Flow per Share	$1.27
Operating Cash Flow per Share	$1.53

Data from Zacks Investment Research, Inc.